Tandem Diabetes won FDA approval for its t:slim X2 insulin pump with Basal-IQ, a technology that prevents hypoglycemia. Basal-IQ, known as a predictive low glucose suspend (PLGS) feature, monitors a number of parameters and prevents insulin delivery when there’s a high chance that would result in a low glucose event.
The system can be used b (Read more...)